InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Brown Douglas Matthew, Executive. Officer active across 1 company, notably Neogenomics INC. Cumulatively, 4 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.1m. Activity tracked since 23 November 2021. The latest transaction was filed on 1 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Brown Douglas Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
82,305 shares0Common StockSEC:0001077183-22-000054:0
35,030 shares0Common StockSEC:0001077183-22-000039:0
30,572 shares0Common StockSEC:0001077183-21-000271:0
33,333 shares@ US$37.19100.0% of flowCommon StockSEC:0001077183-21-000249:0
4 of 4 declarations
About Brown Douglas Matthew
Douglas Matthew Brown is the Chief Strategy Officer at Neogenomics Inc. He is responsible for developing and implementing the company's strategy. Neogenomics specializes in genetic diagnostic services. Douglas's expertise in strategy is essential for the company's growth and innovation.
